Management of Acute Respiratory Distress with Mediastinal Adenopathy and Bilateral Ground-Glass Opacities in an Asthmatic Patient
This patient requires immediate hospital admission with urgent diagnostic workup to differentiate between acute severe asthma exacerbation and alternative life-threatening diagnoses such as hypersensitivity pneumonitis, infection, or pulmonary hemorrhage—the presence of mediastinal adenopathy and diffuse ground-glass opacities is atypical for uncomplicated asthma and mandates broader investigation while simultaneously treating for potential severe asthma.
Immediate Stabilization and Assessment
Initial Management (First 30 Minutes)
Administer high-flow oxygen (40-60%) immediately to maintain SpO2 >92%, as CO2 retention is not aggravated by oxygen therapy in asthma 1, 2.
Give nebulized bronchodilators: salbutamol 5 mg or terbutaline 10 mg via nebulizer with oxygen 1. However, consider ipratropium bromide (0.5 mg nebulized) as primary bronchodilator rather than beta-agonists alone, as it provides bronchodilation without significant cardiac stimulation in tachycardic patients 2.
Administer systemic corticosteroids immediately: prednisolone 30-60 mg orally OR hydrocortisone 200 mg IV (or both if very ill), as these require 6-12 hours to manifest anti-inflammatory effects 1, 2, 3.
Measure arterial blood gases in all patients with acute severe asthma admitted to hospital, looking specifically for normal or elevated PaCO2 (5-6 kPa or higher), severe hypoxia (PaO2 <8 kPa), or low pH—these are markers of life-threatening attack 1.
Obtain peak expiratory flow (PEF) measurement immediately and repeat 15-30 minutes after starting treatment 1.
Critical Diagnostic Workup
The imaging findings are NOT typical for uncomplicated asthma exacerbation and require urgent investigation:
Obtain chest radiograph immediately to exclude pneumothorax, consolidation, or pulmonary oedema 1.
Order complete blood count with differential to assess for eosinophilia (suggesting eosinophilic pneumonia or hypersensitivity pneumonitis) 1, 4.
Measure plasma electrolytes, urea, and in older patients obtain ECG 1.
The combination of mediastinal adenopathy with bilateral ground-glass mosaic opacities suggests alternative diagnoses including hypersensitivity pneumonitis (which characteristically shows centrilobular nodules, ground-glass opacification, mosaic attenuation, and the "three-density sign") 1, 5, infection (viral pneumonias, atypical organisms), pulmonary hemorrhage, or organizing pneumonia 6, 7.
Risk Stratification and Monitoring
Life-Threatening Features Requiring ICU Transfer
Transfer to ICU immediately if ANY of the following are present 1:
- PEF <33% of predicted or best
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma
- Deteriorating PEF, worsening or persisting hypoxia (PaO2 <8 kPa despite 60% oxygen), or hypercapnia (PaCO2 >6 kPa)
Continuous Monitoring Requirements
- Continuous cardiac monitoring for heart rate, rhythm, and blood pressure 2.
- Pulse oximetry with supplemental oxygen titrated to SpO2 >92% 1, 2.
- Serial PEF measurements every 15-30 minutes initially, then every 4 hours as condition stabilizes 1, 2.
- Repeat blood gas measurements within 2 hours if initial PaO2 <8 kPa, initial PaCO2 was normal or raised, or patient deteriorates 1.
Treatment Algorithm Based on Response
If Patient Improves After Initial Treatment
- Continue 40-60% oxygen 1.
- Continue prednisolone 30-60 mg daily or IV hydrocortisone 200 mg every 6 hours 1, 3.
- Give nebulized β-agonist every 4 hours 1.
If No Improvement After 15-30 Minutes
- Continue oxygen and steroids 1.
- Give nebulized β-agonists more frequently (up to every 15 minutes) 1.
- Add ipratropium 0.5 mg to nebulizer and repeat 6-hourly until patient is improving 1.
- Consider IV aminophylline (250 mg over 20 minutes) for patients whose condition is very severe or who fail to improve rapidly with oxygen, steroids, and β-agonists alone 1. Do NOT give bolus aminophylline to patients already taking oral theophyllines 1.
Critical Safety Considerations
Absolute Contraindications
- NO sedatives or anxiolytics (benzodiazepines, opioids)—these are absolutely contraindicated in asthmatic patients and can cause respiratory depression 1, 2.
- Avoid non-selective beta-blockers (propranolol, carvedilol) which can precipitate severe bronchospasm 2.
- Antibiotics only if bacterial infection is confirmed—not routinely indicated 1.
- Percussive physiotherapy is unnecessary 1.
Addressing the Atypical Imaging Findings
Differential Diagnosis Considerations
The mediastinal adenopathy with bilateral ground-glass mosaic opacities is NOT consistent with typical asthma exacerbation and requires specific investigation for:
Hypersensitivity pneumonitis: Look for occupational/environmental exposures (birds, mold, hot tubs); characteristic CT findings include centrilobular nodules, mosaic attenuation with "three-density sign," and lobular air-trapping on expiratory images 1, 5.
Infection: Viral pneumonias (influenza, COVID-19, cytomegalovirus) can present with ground-glass opacities and mediastinal adenopathy 6, 8.
Pulmonary hemorrhage or alveolar hemorrhage syndromes: Consider if bronchoalveolar lavage shows increasingly blood-tinged fluid 4.
Organizing pneumonia or eosinophilic pneumonia: Peripheral ground-glass opacities are typical, though mediastinal adenopathy is less common 7, 4.
Malignancy: Lung cancer, lymphoma, or extrathoracic cancer are common causes of mediastinal lymphadenopathy 8.
Recommended Additional Investigations
- Detailed environmental and occupational exposure history is critical to establishing potential inhaled antigen sources for hypersensitivity pneumonitis 1.
- Consider bronchoscopy with bronchoalveolar lavage if diagnosis remains unclear after initial workup, to assess for eosinophilia, hemorrhage, or infection 1, 4.
- Tissue diagnosis via EBUS-TBNA or EUS-FNA may be necessary for mediastinal adenopathy if malignancy or granulomatous disease (sarcoidosis, tuberculosis) is suspected 8.
Disposition and Follow-Up
Criteria for Hospital Admission
Immediate hospital referral is required if ANY of the following persist after initial treatment 1:
- Any life-threatening features
- Any features of severe attack that persist after initial treatment
- PEF 15-30 minutes after nebulization <33% of predicted or best value
Lower threshold for admission applies to patients 1:
- Seen in afternoon or evening rather than earlier in day
- With recent onset of nocturnal symptoms or worsening symptoms
- Who have had previous severe attacks, especially if onset was rapid
- With concern over assessment of severity or social circumstances
Discharge Criteria (Only After Diagnostic Workup Complete)
Patients should NOT be discharged until alternative diagnoses are excluded and the following criteria are met 1, 9:
- Been on discharge medication for 24 hours with inhaler technique checked and recorded
- PEF >75% of predicted with variability <25%
- Treatment with oral and inhaled bronchodilators and written self-management plan
- GP follow-up arranged within 1 week
- Follow-up appointment in respiratory clinic within 4 weeks
- Peak flow meter provided with instructions for self-monitoring 2, 9
Key Clinical Pitfall
The most critical error would be attributing all findings to asthma exacerbation without investigating the atypical imaging features. Mediastinal adenopathy and diffuse bilateral ground-glass mosaic opacities are NOT typical for uncomplicated asthma and suggest concurrent or alternative pathology that may require specific treatment beyond standard asthma management 1, 6, 5, 8, 7. While treating for potential severe asthma is appropriate given the patient's history and acute presentation, simultaneous diagnostic workup for hypersensitivity pneumonitis, infection, or other interstitial lung processes is mandatory to prevent missing a treatable or life-threatening condition.